Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,808.12
-1.74(-0.03%)
Dow 30
42,114.40
-259.96(-0.61%)
Nasdaq
18,518.61
+103.12(+0.56%)
Russell 2000
2,207.99
-10.93(-0.49%)
Crude Oil
71.69
+1.50(+2.14%)
Gold
2,760.80
+11.90(+0.43%)

Standard BioTools Inc. (LAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.6800

-0.0500

(-2.89%)

At close: 04:00PM EDT

1.6800

0.00

(0.00%)

After hours:

06:07PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	623.54M
Enterprise Value	319.38M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.54
Price/Book (mrq)	1.22
Enterprise Value/Revenue	2.34
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	1.58
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	3.0400
52 Week Low ³	1.2100
50-Day Moving Average ³	1.9290
200-Day Moving Average ³	2.2357

Share Statistics

Avg Vol (3 month) ³	2.03M
Avg Vol (10 day) ³	1.13M
Shares Outstanding ⁵	371.15M
Implied Shares Outstanding ⁶	N/A
Float ⁸	48.76M
% Held by Insiders ¹	1.95%
% Held by Institutions ¹	72.16%
Shares Short (Sep 30, 2024) ⁴	21.29M
Short Ratio (Sep 30, 2024) ⁴	13.44
Short % of Float (Sep 30, 2024) ⁴	11.82%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	5.74%
Shares Short (prior month Aug 30, 2024) ⁴	22.23M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:2
Last Split Date ³	Dec 06, 2001

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2021

Profitability

Profit Margin	-87.05%
Operating Margin (ttm)	-29.42%

Management Effectiveness

Return on Assets (ttm)	-13.28%
Return on Equity (ttm)	-33.51%

Income Statement

Revenue (ttm)	136.3M
Revenue Per Share (ttm)	0.66
Quarterly Revenue Growth (yoy)	-14.20%
Gross Profit (ttm)	N/A
EBITDA	-104.31M
Net Income Avi to Common (ttm)	-164.66M
Diluted EPS (ttm)	-0.8800
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	28.45M
Total Cash Per Share (mrq)	0.37
Total Debt (mrq)	111.65M
Total Debt/Equity (mrq)	118.03
Current Ratio (mrq)	3.88
Book Value Per Share (mrq)	1.23

Cash Flow Statement

Operating Cash Flow (ttm)	-127M
Levered Free Cash Flow (ttm)	-54.07M